Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
Cognyte Software
CGNT
$651M
| $4.19M | 0.01% |
517,377
-49,534
| -9% | -$409K |
2022 Q1
16 quarters
|
|
1477
Sana Biotechnology
SANA
$835M
| $4.18M | 0.01% |
1,451,200
-239,916
| -14% | -$945K |
2025 Q2
3 quarters
|
|
1478
Nordic American Tanker
NAT
$1.79B
| $4.15M | 0.01% |
708,107
+66,700
| +10% | +$316K |
2023 Q3
10 quarters
|
|
1479
Sprout Social
SPT
$667M
| $4.15M | 0.01% |
727,762
+322,200
| +79% | +$2.48M |
2025 Q2
3 quarters
|
|
1480
N-able
NABL
$875M
| $4.11M | 0.01% |
880,500
+357,500
| +68% | +$2M |
2022 Q1
16 quarters
|
|
|
RMAX
1481
DELISTED
RE/MAX Holdings
RMAX
| $4.11M | 0.01% |
713,565
-24,700
| -3% | -$171K |
2015 Q1
44 quarters
|
|
1482
Pathward Financial
CASH
$1.49B
| $4.11M | 0.01% |
+46,058
| New | +$4.01M |
2026 Q1
0 quarters
|
|
1483
RLI Corp
RLI
$5.11B
| $4.08M | 0.01% |
+71,500
| New | +$4.29M |
2026 Q1
0 quarters
|
|
1484
J. Jill
JILL
$364M
| $4.08M | 0.01% |
355,600
-13,800
| -4% | -$220K |
2018 Q3
30 quarters
|
|
1485
Kaiser Aluminum
KALU
$2.48B
| $4.07M | 0.01% |
33,814
+26,514
| +363% | +$3.36M |
2025 Q1
4 quarters
|
|
1486
Viemed Healthcare
VMD
$363M
| $4.07M | 0.01% |
442,200
+1,400
| +0.3% | +$11.7K |
2019 Q3
26 quarters
|
|
|
OPRA
1487
Opera Ltd
OPRA
$1.56B
| $4.06M | 0.01% |
284,801
+53,000
| +23% | +$733K |
2025 Q1
4 quarters
|
|
1488
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.8B
| $4.06M | 0.01% |
+88,900
| New | +$4.17M |
2026 Q1
0 quarters
|
|
1489
Schneider National
SNDR
$5.52B
| $4.05M | 0.01% |
153,600
+125,000
| +437% | +$3.46M |
2025 Q3
2 quarters
|
|
1490
Novavax
NVAX
$2.1B
| $4.05M | 0.01% |
+497,383
| New | +$4.51M |
2026 Q1
0 quarters
|
|
1491
Ponce Financial Group
PDLB
$485M
| $4.05M | 0.01% |
242,135
+21,888
| +10% | +$361K |
2018 Q3
30 quarters
|
|
|
BLLN
1492
BillionToOne Inc
BLLN
$4.63B
| $4.05M | 0.01% |
+51,254
| New | +$4.2M |
2026 Q1
0 quarters
|
|
1493
Backblaze
BLZE
$786M
| $4.05M | 0.01% |
1,172,657
+361,905
| +45% | +$1.52M |
2022 Q1
16 quarters
|
|
1494
Compass Minerals
CMP
$957M
| $4.04M | 0.01% |
172,911
+157,111
| +994% | +$3.7M |
2025 Q3
2 quarters
|
|
1495
LifeMD
LFMD
$127M
| $4.04M | 0.01% |
1,118,325
-380,000
| -25% | -$1.31M |
2022 Q4
13 quarters
|
|
1496
Eton Pharmaceutcials
ETON
$1.58B
| $4.03M | 0.01% |
163,321
-42,379
| -21% | -$741K |
2023 Q1
12 quarters
|
|
1497
Employers Holdings
EIG
$887M
| $4.02M | 0.01% |
97,700
-69,300
| -41% | -$2.93M |
2014 Q2
47 quarters
|
|
1498
Vestis
VSTS
$1.87B
| $4M | 0.01% |
509,100
-64,700
| -11% | -$473K |
2023 Q4
9 quarters
|
|
1499
TriMas Corp
TRS
$1.37B
| $3.98M | 0.01% |
110,700
-121,200
| -52% | -$4.35M |
2025 Q2
3 quarters
|
|
|
NAVN
1500
Navan Inc
NAVN
$6.16B
| $3.98M | 0.01% |
+300,417
| New | +$3.57M |
2026 Q1
0 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.